Week in Review: Antibody Blocks Infection by SARS-CoV-2 in Cells

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

5. Update on Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency

On April 15, the FDA issued a new guidance addressing the compounding of alcohol-based hand sanitizers to further assist pharmacists in state-licensed pharmacies, federal facilities, and registered outsourcing facilities. Read more.

4. Survey Shows Half of Americans Struggling with Mental Health Amid Social Distancing

The findings of a recent survey from ValuePenguin found that 55% of the 1200 respondents said their mental health is suffering because of COVID-19, more specifically in millennials (63%) and parents with younger children (64%). Read more.

3. Prenatal and Postnasal Supplementation: What Do Pharmacists Need to Know?

The results of a 2017 survey by the March of Dimes found that only 34% of women aged 18 to 45 years who took a prenatal vitamin during their current or last pregnancy started the prenatal vitamin before they knew that they were pregnant. Read more.

2. Study Finds Antibody That Blocks Infection by SARS-CoV-2 in Cells

A fully human monoclonal antibody that prevents the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from infecting cultured cells was discovered by researchers at Utrecht University, Erasmus Medical Center, and Harbour BioMed. Read more.

1. Israel Isolates Coronavirus Monoclonal Antibody in Potential COVID-19 Antidote

The Israel Institute for Biological Research (IIBR) presented the country’s Defense Minister Naftali Bennet with a “significant breakthrough” in the search for an antidote to coronavirus disease 2019 (COVID-19). Read more.